Valore202020212022202320242025TTMSpese di vendita, generali e amministrative59.69 M86.16 M121.47 M136.37 M139.59 M136.37 M136.37 MRicerca e sviluppo64.69 M90.9 M126.37 M181.77 M201.78 M173.14 M173.14 MReddito operativo-60.92 M-111.44 M-146.82 M-177.45 M-209.3 M-166.9 M-166.9 MProventi non operativi, Totale34.62 M10.63 M-2.31 M220.37 M23.59 M64.57 M64.57 MOneri finanziari, al netto degli interessi capitalizzati000000—Proventi non operativi, esclusi gli oneri finanziari34.62 M10.63 M-6.26 M200.67 M5.68 M48.17 M48.17 MEntrate/uscite straordinarie——3.95 M19.69 M17.9 M16.4 M16.4 MUtile al lordo delle imposte-26.29 M-100.81 M-149.13 M42.92 M-185.71 M-102.33 M-102.33 MQuota di utile4.11 M-1.78 M11.82 M147.21 M000Imposte345 K411 K63 K2.2 M1.41 M939 K939 KInteressi di minoranza-2.17 M-826 K-3 0000———Altri proventi/oneri al netto delle imposte———————Utile netto al lordo delle attività cessate-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.27 MAttività cessate———————Utile netto-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.27 MRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.27 MUtile base per azione (EPS base)——-2.10.57-2.57-1.41-1.41Utile diluito per azione (EPS diluito)——-2.10.54-2.57-1.41-1.41Numero medio di azioni ordinarie in circolazione——71.17 M71.78 M72.67 M73.44 M293.54 MAzioni diluite in circolazione——71.17 M74.99 M72.67 M73.44 M293.54 MEBITDA-57.26 M-108.6 M-142.47 M-171.9 M-203.14 M-160.87 M-160.87 MEBIT-60.92 M-111.44 M-146.82 M-177.45 M-209.3 M-166.9 M-166.9 MCosto del fatturato44.62 M72.31 M79.93 M75.97 M75.46 M113.25 M113.25 MAltri costi del venduto———————Ammortamento e svalutazione (liquidità)3.66 M2.85 M4.34 M5.55 M6.16 M6.02 M6.02 M
Schrodinger Inc
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.